Evelo Biosciences, Inc.·4

May 31, 4:15 PM ET

McHale Duncan 4

4 · Evelo Biosciences, Inc. · Filed May 31, 2022

Insider Transaction Report

Form 4
Period: 2022-05-27
McHale Duncan
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-05-27$1.46/sh+34,246$49,99934,246 total

Documents

1 file
  • 4
    wf-form4_165402808473244.xmlPrimary

    FORM 4